Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free RNAC Stock Alerts

Cartesian Therapeutics (RNAC) Institutional Ownership

Cartesian Therapeutics logo
$8.84 +0.12 (+1.38%)
Closing price 04:00 PM Eastern
Extended Trading
$8.86 +0.02 (+0.23%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$7.17M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$246.54K
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/6/2026 Bank of New York Mellon Corp31,816$332K0.0%N/A0.108%
5/14/2026 Renaissance Technologies LLC67,300$414K0.0%+63.7%0.229%
5/14/2026Public Employees Retirement System of Ohio13,000$80K0.0%-16.1%0.044%
5/14/2026Sei Investments Co.12,764$78K0.0%N/A0.043%
2/18/2026XTX Topco Ltd10,238$74K0.0%-61.0%0.039%
2/18/2026Millennium Management LLC164,366$1.19M0.0%+548.2%0.632%
2/18/2026683 Capital Management LLC280,000$2.02M0.1%+21.7%1.077%
2/17/2026Jain Global LLC16,724$121K0.0%N/A0.064%
2/17/2026Public Employees Retirement System of Ohio15,500$112K0.0%N/A0.060%
2/16/2026Squarepoint Ops LLC18,213$131K0.0%N/A0.070%
2/13/2026 Marshall Wace LLP178,140$1.28M0.0%+110.1%0.685%
2/13/2026 Walleye Capital LLC43,878$316K0.0%N/A0.169%
2/13/2026Wells Fargo & Company MN11,762$85K0.0%+49.2%0.045%
2/12/2026 Renaissance Technologies LLC41,100$296K0.0%N/A0.158%
2/12/2026 Miller Financial Services LLC13,643$98K0.1%+17.2%0.052%
2/11/2026 Erste Asset Management GmbH271,705$1.96M0.0%+4.5%1.045%
2/9/2026 Geode Capital Management LLC255,539$1.84M0.0%+5.7%0.983%
2/3/2026 Privium Fund Management B.V.172,500$1.24M0.2%N/A0.663%
1/30/2026 R Squared Ltd10,308$74K0.0%N/A0.040%
11/17/2025Jacobs Levy Equity Management Inc.30,001$307K0.0%-27.4%0.115%
11/17/2025Millennium Management LLC25,357$259K0.0%N/A0.098%
11/14/2025Bridgeway Capital Management LLC25,000$256K0.0%N/A0.096%
11/7/2025 GSA Capital Partners LLP86,095$880K0.1%+106.9%0.331%
11/7/2025Vanguard Group Inc.520,722$5.32M0.0%+4.9%2.003%
11/3/2025 AlphaQuest LLC6,924$71K0.0%+64.6%0.027%
8/15/2025Bank of America Corp DE13,933$145K0.0%+133.0%0.054%
8/15/2025683 Capital Management LLC219,000$2.28M0.1%+46.0%0.842%
8/14/2025MPM Bioimpact LLC686,007$7.13M1.2%-13.2%2.638%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,056$53K0.0%-16.0%0.019%
8/13/2025 Marshall Wace LLP82,630$859K0.0%+114.0%0.318%
8/13/2025 Virtus Investment Advisers LLC9,183$95K0.0%+12.5%0.035%
8/12/2025 JPMorgan Chase & Co.6,080$63K0.0%-96.9%0.023%
8/12/2025 Miller Financial Services LLC11,643$121K0.2%N/A0.045%
8/8/2025 Geode Capital Management LLC218,927$2.28M0.0%-2.9%0.844%
7/31/2025 AlphaQuest LLC4,207$44K0.0%-41.5%0.016%
6/27/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/29/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
5/23/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.170%
5/16/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/16/2025683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%
Buy These Stocks Before August 31st (Ad)

Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwide. The analyst, who called the 2020 crash early, is working with a former NSA codebreaker and Pentagon insider on a new approach to AI stocks ahead of August 31. Investors like Stephen and Keith W. say the tools helped shape their portfolios, though results vary and are not typical.tc pixel

Get the full details on Keith Kaplan's AI stock research now
5/15/2025MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%
5/15/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%
5/14/2025AlphaQuest LLC7,191$95K0.0%N/A0.028%
5/14/2025Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%
5/13/2025Twin Focus Capital Partners LLC15,000$198K0.0%+25.0%0.058%
5/12/2025Nuveen LLC27,869$367K0.0%N/A0.107%
5/9/2025Deutsche Bank AG7,424$98K0.0%+104.1%0.029%
5/9/2025Charles Schwab Investment Management Inc.29,303$386K0.0%+9.3%0.113%
4/30/2025Alps Advisors Inc.19,392$256K0.0%-5.6%0.075%
4/29/2025Bank of New York Mellon Corp20,937$276K0.0%+7.9%0.081%
4/8/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
2/17/2025Two Sigma Investments LP11,812$212K0.0%-8.5%0.046%
2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023%
2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%
2/17/2025Bank of America Corp DE11,690$209K0.0%+54.4%0.046%
2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%
2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%
2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%
2/14/2025MetLife Investment Management LLC6,667$119K0.0%N/A0.026%
2/13/2025Barclays PLC19,099$342K0.0%+64.5%0.075%
2/13/2025Renaissance Technologies LLC13,800$247K0.0%N/A0.054%
2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%
2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%
2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%
2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%
2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%
2/6/2025Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105%
2/4/2025Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076%
1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%
1/30/2025Rhumbline Advisers10,201$183K0.0%+10.0%0.040%
1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%
1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%
11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%
11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620%
11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205%
11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787%
11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%
11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219%
10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074%
9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506%
8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
AI insiders stockpile guns, gold & gas masks (Ad)

Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift in the AI market is approaching, and time is short to prepare. Kaplan points to August 31st as a key turning point for AI investing. He argues the next phase will separate winners from losers, and reveals what he's watching instead of big names like Nvidia.tc pixel

See Keith Kaplan's full AI market briefing before August 31st
8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140%
8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421%
8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096%
8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178%
8/1/2024Rhumbline Advisers8,487$229K0.0%-93.5%0.048%
7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112%
7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%
5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%
5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052%


RNAC Institutional Ownership - Frequently Asked Questions

During the previous two years, 56 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Siren L.L.C. ($7.42M), MPM Bioimpact LLC ($7.13M), Citadel Advisors LLC ($5.64M), Vanguard Group Inc. ($5.32M), Great Point Partners LLC ($3.22M), and State Street Corp ($2.54M).Learn more on Cartesian Therapeutics' institutional investors.

86.95% of Cartesian Therapeutics' stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Of the 46 institutional investors that purchased Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.34M), Great Point Partners LLC ($200K), 683 Capital Management LLC ($193.57K), Logos Global Management LP ($180K), Privium Fund Management B.V. ($172.50K), Marshall Wace LLP ($167.40K), and Millennium Management LLC ($164.37K).

Institutional investors have bought a total of 901,503 shares in the last 24 months. This purchase volume represents approximately $7.17M in transactions.

The following institutional investors have sold Cartesian Therapeutics stock in the last 24 months: XTX Topco Ltd ($16.02K), Jacobs Levy Equity Management Inc. ($11.32K), and Public Employees Retirement System of Ohio ($2.50K).

Institutional investors have sold a total of 29,837 shares in the last 24 months. This volume of shares sold represents approximately $246.54K in transactions.


Related Companies

Institutional ownership data for NASDAQ:RNAC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your 10X AI demo is starting…
Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...
TradeSmith | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
How a rare metal shortage sent gains up 2512 percent
In 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...
Awesomely | Sponsoredtc pixel